Professional Context
With a 25% increase in quality assurance audits pending, Genetic Counselors must optimize their workflow to maintain a 95% completion rate within a 3-day turnaround time, all while minimizing error rates below 2%, to ensure compliance with industry standards and accreditation requirements.
💡 Expert Advice & Considerations
Don't waste time on Perplexity for routine patient intake forms; focus on high-stakes, low-frequency tasks like navigating novel variant classifications or drafting policy briefs for emerging genetic technologies.
Advanced Prompt Library
4 Expert PromptsVariant Classification Workflow
Given a novel variant of uncertain significance (VUS) in the BRCA2 gene, with a Minor Allele Frequency (MAF) of 0.001 and a PolyPhen-2 score of 0.8, develop a step-by-step workflow to classify this variant using ACMG guidelines, incorporating functional prediction tools like SIFT and MutationTaster, and including a review of relevant literature from the past 2 years, using a minimum of 5 academic sources, to determine the likelihood of pathogenicity and inform patient management decisions.
Genetic Testing Panel Design
Design a comprehensive genetic testing panel for a patient with a family history of early-onset colorectal cancer, incorporating a minimum of 10 genes associated with increased cancer risk, including MLH1, MSH2, and APC, and considering the patient's ethnic background and medical history, to identify the most likely causative mutations and inform targeted surveillance and prevention strategies, using data from the National Comprehensive Cancer Network (NCCN) and the American College of Medical Genetics and Genomics (ACMG).
Policy Brief: Germline Editing
Develop a policy brief on the ethics and regulatory considerations surrounding germline editing using CRISPR-Cas9 technology, incorporating a review of current laws and guidelines from the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the American Society of Human Genetics (ASHG), as well as international perspectives from the World Health Organization (WHO) and the European Society of Human Genetics (ESHG), to inform institutional policies on the use of this technology in clinical and research settings.
Consent Form Development
Create a patient consent form for a genetic testing study on the genetic basis of neurodevelopmental disorders, incorporating a clear explanation of the purpose, risks, and benefits of the study, as well as the potential implications of genetic findings, using language accessible to a 6th-grade reading level, and including all necessary elements as outlined in the Office for Human Research Protections (OHRP) guidelines, to ensure informed consent and compliance with regulatory requirements.